Last reviewed: June 15, 2026

Last updated: June 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1 receptor agonists have transformed weight loss treatment, with clinical trials showing average weight reductions of 15-22% over one year. Understanding how to get GLP-1 approved involves knowing your medical eligibility, finding the right provider, and selecting a formulation that fits your lifestyle. PlexusDx streamlines this entire process with personalized guidance and affordable access to compounded semaglutide injections.

Understanding GLP-1 Medication Eligibility Requirements

GLP-1 receptor agonist therapy is appropriate for adults with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher combined with weight-related health conditions such as type 2 diabetes, hypertension, or sleep apnea. Age, medical history, and current medications all factor into whether a healthcare provider will recommend GLP-1 treatment. PlexusDx evaluates each patient individually to determine if compounded semaglutide injections align with their health profile and weight loss goals.

Certain medical conditions may require caution or dosage adjustments when using GLP-1 therapy. These include a personal or family history of medullary thyroid cancer, history of severe pancreatitis, or uncontrolled gallbladder disease. Pregnancy and breastfeeding are contraindications, as GLP-1 medications have not been established as safe in these populations. A thorough medical intake ensures that PlexusDx patients receive appropriate guidance before starting treatment.

Steps to Get GLP-1 Approved Through PlexusDx

The first step involves completing a comprehensive health questionnaire that captures your weight history, current medications, medical conditions, and lifestyle factors. PlexusDx uses this information to assess whether you are a good candidate for compounded semaglutide injection therapy. Unlike traditional insurance-based approvals that can take weeks, PlexusDx typically completes this review within 24 hours, allowing eligible patients to start therapy quickly.

Once your eligibility is confirmed, you will connect with a licensed healthcare provider who reviews your case and can authorize treatment. PlexusDx offers flexible communication options, including online consultations and phone appointments, making it convenient to get provider approval without scheduling office visits. After approval, your compounded semaglutide injection is prepared at a licensed 503A compounding pharmacy and shipped directly to your home, with your dose adjusted based on clinical response and tolerance.

Semaglutide Injection vs. Other GLP-1 Delivery Methods

Compounded semaglutide injections offer weekly dosing that many patients find easier to maintain than daily oral medications. The injection format provides reliable absorption and consistent blood levels, supporting steady weight loss and appetite control throughout the week. PlexusDx semaglutide injections start at just $149 per month, making this proven delivery method more affordable than brand-name alternatives while maintaining the same active ingredient and efficacy.

Some patients prefer oral semaglutide, which eliminates the needle but requires daily dosing and may have lower bioavailability than injections. PlexusDx offers oral semaglutide at $249 per month for those seeking a needle-free option. The choice between injection and oral depends on your comfort level, schedule, and response to treatment—both formulations are available without insurance requirements or membership fees.

Personalized Treatment With Precision Peptide Genetic Testing

Individual genetic variations influence how your body responds to GLP-1 therapy, affecting both weight loss success and side effect tolerance. PlexusDx Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptides to identify genetic markers such as GIPR rs1800437, GLP1R rs6923761, and FTO rs9939609 that predict your personalized response to semaglutide and other GLP-1 medications. This peptide-pathway genetic insight, available for $99 after your first month of treatment, allows your healthcare provider to optimize your dosing strategy and medication choice based on your unique biology.

Patients with genetic predispositions favoring strong GLP-1 receptor sensitivity may achieve significant weight loss at lower doses, while others may benefit from combination therapy or alternative formulations. Understanding your genetic profile helps PlexusDx providers fine-tune treatment from the start, reducing trial-and-error adjustments and increasing the likelihood of long-term success. This precision approach moves beyond a one-size-fits-all model to deliver weight loss therapy tailored to your body's actual chemistry.

Cost and Insurance Considerations for GLP-1 Access

PlexusDx compounded semaglutide injections start at $149 per month on the most affordable commitment tier, with no insurance required and no membership fees. This transparent pricing model means your dose may increase as your provider adjusts your therapy for optimal results, but your monthly price remains flat across all dose levels. The affordability of compounded semaglutide through PlexusDx makes this weight loss medication accessible to patients who face barriers with brand-name medications or high insurance deductibles.

Patients with health savings accounts (HSA) or flexible spending accounts (FSA) can use these pre-tax funds to cover PlexusDx compounded medications, reducing out-of-pocket costs further. PlexusDx accepts payment through multiple methods and offers flexible billing options to support consistent access to therapy. For patients with insurance coverage of GLP-1 medications, PlexusDx remains an affordable alternative or supplementary option, especially when considering the speed of approval and convenience of direct-to-home delivery.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Do I need a prescription to get GLP-1 approved through PlexusDx?

Yes, a licensed healthcare provider must review your medical history and authorize GLP-1 therapy. PlexusDx connects you with a provider during the approval process, and they issue a prescription for compounded semaglutide injection once you meet eligibility criteria. The entire approval process typically takes 24 hours or less.

What weight loss results can I expect from compounded semaglutide?

Clinical trials show that patients using semaglutide typically lose 15-22% of their body weight over one year when combined with lifestyle modifications. Individual results vary based on genetics, adherence, diet, and exercise. PlexusDx Precision Peptide Genetic Testing can help predict your personalized response by analyzing genetic markers that influence GLP-1 receptor sensitivity and metabolic pathways.

How much does semaglutide injection cost at PlexusDx?

PlexusDx compounded semaglutide injection starts at $149 per month with no insurance required. Your dose may increase during treatment as your provider optimizes your therapy, but your monthly price remains flat. HSA and FSA funds are also accepted to reduce out-of-pocket costs.

Are compounded GLP-1 medications safe?

Yes, PlexusDx sources all compounded medications from licensed 503A compounding pharmacies that follow strict quality and sterility standards. Compounded semaglutide contains the same active ingredient as brand-name versions but at a lower cost. Common side effects include nausea, constipation, and appetite suppression—most mild and temporary. Serious side effects are rare but require immediate medical attention.

What does the PlexusDx Precision Peptide Genetic Test reveal?

The Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptides, including genetic variants like GLP1R rs6923761, GIPR rs1800437, and FTO rs9939609 that predict your response to semaglutide and other GLP-1 therapies. This $99 test (available after your first treatment month) helps your PlexusDx provider personalize your dosing and medication selection based on your unique peptide biology, not just generic pharmacogenomics.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves